Mural Oncology PLC (MURA)
3.37
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
3.36
-0.01
(-0.30%)
Pre-Market: 20:00
Mural Oncology Enterprise Value: -118.01M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -118.01M |
| November 20, 2024 | -118.01M |
| November 19, 2024 | -118.01M |
| November 18, 2024 | -118.18M |
| November 15, 2024 | -116.64M |
| November 14, 2024 | -115.96M |
| November 13, 2024 | -115.45M |
| November 12, 2024 | -115.45M |
| November 11, 2024 | -113.74M |
| November 08, 2024 | -115.45M |
| November 07, 2024 | -117.84M |
| November 06, 2024 | -118.01M |
| November 05, 2024 | -118.52M |
| November 04, 2024 | -117.50M |
| November 01, 2024 | -116.47M |
| October 31, 2024 | -115.52M |
| October 30, 2024 | -114.84M |
| October 29, 2024 | -114.33M |
| October 28, 2024 | -113.65M |
| October 25, 2024 | -115.69M |
| October 24, 2024 | -116.03M |
| October 23, 2024 | -116.72M |
| October 22, 2024 | -113.48M |
| October 21, 2024 | -113.14M |
| October 18, 2024 | -113.31M |
| Date | Value |
|---|---|
| October 17, 2024 | -112.63M |
| October 16, 2024 | -112.12M |
| October 15, 2024 | -116.72M |
| October 14, 2024 | -117.06M |
| October 11, 2024 | -116.55M |
| October 10, 2024 | -117.23M |
| October 09, 2024 | -118.08M |
| October 08, 2024 | -116.38M |
| October 07, 2024 | -117.40M |
| October 04, 2024 | -118.25M |
| October 03, 2024 | -120.98M |
| October 02, 2024 | -122.34M |
| October 01, 2024 | -122.17M |
| September 30, 2024 | -122.17M |
| September 27, 2024 | -152.74M |
| September 26, 2024 | -153.08M |
| September 25, 2024 | -150.18M |
| September 24, 2024 | -150.18M |
| September 23, 2024 | -149.33M |
| September 20, 2024 | -147.12M |
| September 19, 2024 | -145.75M |
| September 18, 2024 | -145.92M |
| September 17, 2024 | -147.80M |
| September 16, 2024 | -149.50M |
| September 13, 2024 | -148.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-203.59M
Minimum
Jan 18 2024
100.31M
Maximum
Dec 28 2023
-133.51M
Average
-153.08M
Median
Sep 09 2024
Enterprise Value Benchmarks
| Amarin Corp PLC | -89.82M |
| Jazz Pharmaceuticals PLC | 11.06B |
| Prothena Corp PLC | 257.74M |
| Iterum Therapeutics PLC | 31.18M |
| GH Research PLC | 350.47M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.76M |
| Total Expenses (Quarterly) | 34.10M |
| EPS Diluted (Quarterly) | -1.87 |
| Earnings Yield | -271.1% |